AML, Adult

Palliative Care Oncology in Patients With Relapsed, Refractory, and High-Risk Leukemias or MDS

Revumenib in Combination With 7+3 + Midostaurin in AML

VAG Versus Standard Chemotherapy With FLT3 Inhibitor in Adult Patients With FLT3-Mutated AML

Comparison of VA and D/IA Induction Regimens in Elderly Fit Acute Myeloid Leukemia Patients

A Study of BN104 in the Treatment of Acute Leukemia

Quality of Life-Guided Transfusion in Refractory MDS or AML

Natural Killer(NK) Cell Therapy in Acute Myeloid Leukemia

Quality of Life Model for Older Patients With AML

OBServatory of Compassionate Use of IVOsidenib in France for Patients With Acute Myeloid Leukemia

Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML

Pitavastatin in Combination With Venetoclax for Chronic Lymphocytic Leukemia or Acute Myeloid Leukemia

MRD-positive AML Clinical Study

Observational Study on the Outcome of AML Patients Treated With New Drugs in Real-life (BoxTrial)

Venetoclax-Decitabine in Untreated Elderly/Unfit AML

Assessment of Geriatric Evaluations Impact on New AML Guidance

Pharmacoscopy-guided Clinical Standard-of-care in r/r AML

Study Investigating the Efficacy and Safety of the Addition of Oral-azacitidine to Salvage Treatment by Gilteritinib in Subjects ≥18 Years of Age With Relapsed/Refractory FLT3-mutated Acute Myeloid Leukemia

Epidemiological Study of a Prospective Cohort of Patients Aged 60 and Over Managed for Acute Myeloid Leukemia (AML) and Receiving Intensive Induction Therapy

A Study to Evaluate the STI-8591 in Subjects With Advanced Acute Myeloid Leukemia (AML)

Study of Tretinoin Capsules in Combination With Azacitidine and Venetoclax in Treatment Naïve Participants With Acute Myeloid Leukemia